In 2024, we saw the expanded use of synthetic data and natural language processing transform drug discovery and development. In a batch of predictions published in December of 2023, one expert predicted that synthetic data was set to “take off” in drug research. In 2025, the pendulum could begin swinging back the other way, according…
QuantHealth’s AI simulates 100+ clinical trials with 85% accuracy
QuantHealth, an AI-focused clinical trial design company based out of Tel Aviv, has announced the completion of more than 100 simulated clinical trials, reporting an 85% accuracy rate. The company, which received $17 million in a Series A funding round with backing from Accenture, aims to chip away at the steep costs and stubborn timelines…
How ConcertAI and NVIDIA’s AI tools are architecting faster and smarter cancer trials
Imagine tripling or quadrupling the speed at which eligible patients are matched to potentially life-saving cancer trials. That’s the promise of ConcertAI’s AI-powered screening technology, which demonstrated a 3 to 4 times efficiency gain over traditional EMR-based methods in a recent study presented at the American Society of Clinical Oncology (ASCO) conference. Focusing on relapsed…
3 ways to reduce implicit bias in predictive analytics for better health equity
The COVID-19 pandemic has brought into sharp focus the racioethnic and socioeconomic disparities inherent in the U.S. healthcare system. These disparities take the form of increased adverse health outcomes and reduced quality of life for affected groups. For example, a study of cities that reported COVID-19 deaths by race and ethnicity found that 34% of…